China Vascular Intervention Devices Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Vascular Intervention Devices Market was valued at USD 1.95 billion in 2025 and is projected to reach USD 2.74 billion by 2032, growing at a CAGR of approximately 5% during 2026–2032.
China Vascular Intervention Devices Market Highlights
| Report Metric | Details |
| Report Name | China Vascular Intervention Devices Market |
| Market Size 2025 | USD 1.95 billion |
| Market Size 2032 | USD 2.74 billion |
| Absolute Growth 2025–2032 | USD 0.79 billion |
| CAGR 2026–2032 | 5% |
| Peak Annual Growth | 7.5% in 2030 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Device Type, 2025 | Drug-Eluting Stents (50% share) |
| Leading Technique Used, 2025 | Angioplasty (40% share) |
| Leading Target Vessels, 2025 | Coronary Arteries (49% share) |
| Leading End User, 2025 | Hospitals (43% share) |
| Fastest-Growing Device Type | Thrombectomy Devices (7.0% CAGR) |
| Fastest-Growing Technique Used | Clot Removal (7.7% CAGR) |
| Fastest-Growing Target Vessels | Peripheral Arteries (6.5% CAGR) |
| Fastest-Growing End User | Stroke Centers (6.5% CAGR) |
| Growing Sector | hospitals |
| Key End Users | hospitals, stroke centers, vascular clinics, cardiology labs |
China Vascular Intervention Devices Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 6.3 | The market experienced strong demand due to the increasing prevalence of cardiovascular diseases. |
| 2023 | 2.5 | Growth slowed as hospitals adjusted to the implementation of the National Cardiovascular Disease Prevention and Control Plan. |
| 2024 | 4.4 | Demand picked up with the expansion of vascular intervention programs in urban hospitals. |
| 2025 | 5.5 | Increased funding from the Ministry of Health for cardiovascular health initiatives boosted purchasing in hospitals. |
| 2026 | 6.5 | The introduction of new technologies in vascular devices is expected to spur further demand. |
| 2027 | 5.1 | Growth is projected to slow as market saturation begins to affect purchasing decisions. |
| 2028 | 3.5 | Demand is expected to continue slowing as hospitals face budget constraints and resource limitations. |
| 2029 | 4.0 | A recovery in growth is anticipated as new treatment protocols are adopted in facilities. |
| 2030 | 7.5 | The market is projected to peak with heightened investments in advanced vascular technologies. |
| 2031 | 3.7 | Growth is expected to slow as the market begins to stabilise after rapid expansion. |
| 2032 | 4.6 | Demand is projected to increase again as the aging population continues to drive healthcare needs. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Vascular Intervention Devices Market Synopsis
The China Vascular Intervention Devices Market consists of medical tools designed to treat vascular diseases through minimally invasive procedures. These devices are manufactured using advanced materials and technologies, primarily for coronary artery and peripheral artery diseases. The market is growing due to an aging population and a rise in cardiovascular disease cases, with hospitals being the primary buyers. The National Health Commission's "Cardiovascular Health Improvement Program" is improving treatment access, driving demand for these essential medical devices.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising prevalence of cardiovascular diseases increases demand for treatment solutions. | Driver | High | Drug-Eluting Stents |
| Growing investments in healthcare infrastructure enhance access to vascular interventions. | Driver | High | Angioplasty |
| Increasing number of stroke centers creates a need for advanced vascular devices. | Opportunity | High | Thrombectomy Devices |
| Expansion of urban hospitals boosts demand for vascular intervention technologies. | Opportunity | High | Balloon Catheters |
| High costs of advanced vascular devices may limit hospital budgets. | Restraint | Medium | Drug-Eluting Stents |
| Regulatory hurdles in device approval can delay market entry for new products. | Restraint | Medium | Thrombectomy Devices |
| The market faces challenges due to the high operational costs for hospitals. | Challenge | High | Angioplasty |
| Limited availability of skilled professionals can hinder the adoption of new technologies. | Challenge | High | Drug-Eluting Stents |
Evaluation of Drivers in China Vascular Intervention Devices Market (2026–2032)
Below mentioned are some major drivers and their influence on market dynamics.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased cardiovascular disease cases drive demand for vascular intervention devices. | Drug-Eluting Stents | In 2023, cardiovascular disease cases rose by 20%, prompting hospitals to purchase more devices. |
| Expansion of healthcare facilities increases access to vascular interventions. | Angioplasty | With over 1,000 hospitals equipped for interventions, demand for devices is on the rise. |
| Investment in stroke centers boosts the need for thrombectomy devices. | Thrombectomy Devices | The establishment of over 300 stroke centers increases the demand for advanced devices. |
| Growing urban population leads to higher demand for vascular procedures. | Balloon Catheters | Approximately 60% of vascular interventions occur in urban hospitals, increasing device purchases. |
| Government funding for cardiovascular health initiatives supports device procurement. | Drug-Eluting Stents | In 2023, 1 billion yuan was allocated for cardiovascular disease prevention initiatives. |
Growth in the Vascular Intervention Devices market in China comes from increased cardiovascular disease cases, expanding healthcare infrastructure, and rising investments in urban hospitals. In 2023, cardiovascular disease cases rose by 20%, prompting hospitals to purchase more devices. With over 1,000 hospitals equipped for interventions, demand for angioplasty devices is on the rise. The establishment of over 300 stroke centers boosts the demand for advanced thrombectomy devices.
Evaluation of Restraints in China Vascular Intervention Devices Market
The main factors holding the market back are set out below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| High costs of advanced vascular devices may limit hospital budgets. | Drug-Eluting Stents | The average cost of advanced devices can exceed hospital budgets, affecting procurement. |
| Regulatory hurdles in device approval can delay market entry for new products. | Thrombectomy Devices | Stringent regulations can extend approval times, limiting device availability in hospitals. |
| Limited reimbursement for certain procedures can restrict device usage. | Angioplasty | Hospitals may hesitate to invest in devices without guaranteed reimbursement from insurers. |
| Market saturation in urban areas may slow growth rates. | Balloon Catheters | As urban hospitals reach capacity, demand for additional devices may decline. |
| Competition from alternative treatment methods can impact device sales. | Drug-Eluting Stents | Emerging therapies may divert funding away from traditional vascular intervention devices. |
China Vascular Intervention Devices Market Challenges
The China Vascular Intervention Devices Market encounters several practical issues, starting with rising production costs due to increasing raw material prices. This rise forces producers to elevate prices, which directly affects hospitals struggling to maintain budgets while delivering necessary treatments. Supply chain disruptions also present a major challenge, delaying the delivery of essential devices to medical facilities and extending patient wait times for procedures. Furthermore, a shortage of skilled technicians in the vascular intervention sector restricts clinics' ability to perform procedures efficiently, leading to longer treatment delays for patients seeking care.
Trends in the China Vascular Intervention Devices Market
Buyers and suppliers in the China Vascular Intervention Devices Market are adjusting to the following trends.
- Shift towards Minimally Invasive Procedures: China is increasingly embracing minimally invasive techniques for vascular interventions, reflecting patient preference for shorter recovery times. In 2023, over 1 million angioplasty procedures were conducted.
- Increased Focus on Stroke Treatment: The establishment of specialised stroke centres in China is transforming treatment approaches, with over 300 centres now operational. This change has resulted in a 15% increase in funding for vascular health programmes.
- Adoption of Drug-Eluting Stents: Drug-eluting stents are now utilised in over 80% of coronary interventions in urban hospitals, highlighting their growing importance in vascular treatment. This trend is backed by national standards established under GB/T 19633-2019.
- Expansion of Healthcare Infrastructure: The Beijing-Tianjin-Hebei region is experiencing investments in healthcare infrastructure, improving access to vascular interventions. The installed base of angioplasty devices reached approximately 500,000 units in 2023.
Investment Opportunities in the China Vascular Intervention Devices Market
Several openings in the China Vascular Intervention Devices Market merit attention from investors.
- Hospitals Seeking Advanced Treatment Solutions: Urban hospitals are increasingly in search of advanced vascular intervention devices, driven by the rising prevalence of cardiovascular diseases. This presents a strong investment opportunity for suppliers in this sector.
- Timing for New Product Launches: With a projected increase in cardiovascular disease cases, now is the perfect time to introduce new vascular devices. The market is expected to grow considerably in the coming years, creating demand for new products.
- Joint Ventures for Local Manufacturing: Local partnerships can facilitate the introduction of new vascular devices into the Chinese market. Collaborating with established hospitals can streamline the approval process and improve market access.
- Funding for Cardiovascular Health Programs: The Chinese government allocated 1 billion yuan for cardiovascular disease prevention initiatives, creating opportunities for suppliers of vascular devices to meet the growing demand.
Government Initiatives in the China Vascular Intervention Devices Market
In 2023, the National Medical Products Administration updated the approval pathway for vascular intervention devices, streamlining the process for new technologies. This measure builds on the National Cardiovascular Disease Prevention and Control Plan (2021-2025), which aims to improve treatment strategies for vascular diseases. By simplifying approvals, the government encourages innovation and faster market entry for new devices, benefiting both producers and patients. The Ministry of Industry and Information Technology also initiated the Medical Device Innovation Action Plan in 2022, aiming to boost local manufacturing of vascular devices.
In 2023, the Chinese government allocated 1 billion yuan for cardiovascular disease prevention initiatives, administered by the National Health Commission. This funding supports research and development in vascular intervention technologies, ensuring that hospitals have access to the latest devices. The National Health Commission also oversees the implementation of the Cardiovascular Health Improvement Program, which improves treatment access for patients.
Future Insight of the China Vascular Intervention Devices Market
The China Vascular Intervention Devices Market is set for transformative changes by 2032, driven by advancements in technology and supportive government initiatives. The "Cardiovascular Health Improvement Program" will improve treatment access, while national standards like GB/T 19633-2019 will uphold device quality. In 2023, over 1 million angioplasty procedures were performed, reflecting strong demand for these interventions. Investments in the Shanghai region will further stimulate innovation, enabling suppliers to address the rising needs of hospitals and clinics as cardiovascular disease prevalence continues to increase.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Device Type – Drug-Eluting Stents Dominated, Thrombectomy Devices Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, the largest device type category in 2025 was Drug-Eluting Stents, with a 50% share of total revenue. Drug-eluting stents hold the largest share in China's vascular intervention devices market due to their extensive use in over 80% of coronary interventions performed in urban hospitals. Their unique capability to release medication that prevents restenosis makes them essential for effective treatment of coronary artery disease. Thrombectomy Devices are set to record the highest CAGR in this split, 7.0% over 2026–2032. Thrombectomy devices are rapidly gaining traction, largely due to the annual performance of over 1 million angioplasty procedures that create a demand for effective clot removal solutions. The reported 20% rise in cardiovascular disease cases further accelerates the need for these devices. Suppliers should focus on thrombectomy devices to capitalise on the growing demand and improve treatment options for patients.
By Technique Used – Angioplasty Dominated, Clot Removal Expected to Grow Fastest
In 2025, Angioplasty led the technique used split with a 40% share. Angioplasty is the leading technique in the vascular intervention market, primarily used to widen narrowed arteries and improve blood flow. Its prevalent application in hospitals across China underscores its effectiveness in treating coronary artery disease and enhancing patient outcomes. Over 2026–2032, Clot Removal is expected to post the fastest growth, at a CAGR of 7.7%. Clot removal techniques are witnessing rapid growth, driven by the increasing prevalence of cardiovascular diseases necessitating timely interventions. The establishment of more stroke centres across major cities further emphasises the need for effective clot removal solutions. Suppliers must invest in advanced clot removal technologies to align with the rising demand and improve patient care in critical situations.
By Target Vessels – Coronary Arteries Dominated, Peripheral Arteries Expected to Grow Fastest
Coronary Arteries took a 49% share of target vessels in 2025, more than any other category. Coronary arteries are the primary target in the vascular intervention devices market, as they are essential for treating heart-related vascular conditions. The high volume of procedures aimed at these arteries highlights their critical role in managing cardiovascular diseases effectively. Peripheral Arteries are projected to grow fastest, at a CAGR of 6.5% during 2026–2032. Peripheral arteries are experiencing the fastest growth, driven by the rising prevalence of peripheral artery disease, estimated at 8% among adults over 60. This demographic trend increases the demand for targeted interventions in this area. Suppliers should prioritise the development of solutions for peripheral artery treatments to address the growing patient population and enhance their market share.
By End User – Hospitals Dominated, Stroke Centers Expected to Grow Fastest
With a 43% revenue share in 2025, Hospitals was the largest end user category. Hospitals represent the largest end user segment for vascular intervention devices, as they are the primary facilities conducting these procedures. The extensive installed base of angioplasty devices in over 1,000 hospitals in China highlights their critical role in patient care. The quickest growth will come from Stroke Centers, forecast to expand at a CAGR of 6.5% between 2026 and 2032. Stroke centers are rapidly becoming a key focus for vascular interventions, particularly as the government increases funding for cardiovascular health programs. Their specialised approach to treating acute strokes drives the demand for effective vascular devices. Suppliers should target stroke centers to expand their market reach and cater to the urgent needs of acute stroke patients.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Vascular Intervention Devices Market Outlook
- Market Size of China Vascular Intervention Devices Market, 2025
- Forecast of China Vascular Intervention Devices Market, 2032
- Historical Data and Forecast of China Vascular Intervention Devices Revenues & Volume for the Period 2022 - 2032F
- China Vascular Intervention Devices Market Trend Evolution
- China Vascular Intervention Devices Market Drivers and Challenges
- China Vascular Intervention Devices Price Trends
- China Vascular Intervention Devices Porter's Five Forces
- China Vascular Intervention Devices Industry Life Cycle
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Device Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Balloon Catheters for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Drug-Eluting Stents for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Thrombectomy Devices for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Embolic Protection Dev. for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Technique Used for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Angioplasty for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Stent Implant for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Clot Removal for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Filtration/Blockade for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Target Vessels for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Coronary Arteries for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Peripheral Arteries for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Deep Veins/Arteries for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Carotid Arteries for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Cardiology Labs for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Stroke Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Intervention Devices Market Revenues & Volume By Vascular Clinics for the Period 2022 - 2032F
- China Vascular Intervention Devices Import Export Trade Statistics
- Market Opportunity Assessment By Device Type
- Market Opportunity Assessment By Technique Used
- Market Opportunity Assessment By Target Vessels
- Market Opportunity Assessment By End User
- China Vascular Intervention Devices Top Companies Market Share
- China Vascular Intervention Devices Competitive Benchmarking By Technical and Operational Parameters
- China Vascular Intervention Devices Company Profiles
- China Vascular Intervention Devices Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Device Type
- Balloon Catheters
- Drug-Eluting Stents
- Thrombectomy Devices
- Embolic Protection Dev.
By Technique Used
- Angioplasty
- Stent Implant
- Clot Removal
- Filtration/Blockade
By Target Vessels
- Coronary Arteries
- Peripheral Arteries
- Deep Veins/Arteries
- Carotid Arteries
By End User
- Cardiology Labs
- Hospitals
- Stroke Centers
- Vascular Clinics
